BOZEMAN, MONT. – With contaminations of foreign made food and drug products coming to light constantly, consumers have become increasingly and rightfully fearful about the origin of their consumable goods. For example, the contaminations of the blood thinner heparin alone killed over 100 people. The heparin was contaminated in the production process because of lax enforcement of manufacturing rules and regulations. In response to this, recent draft legislation proposed by the U.S. Food and Drug Administration (FDA) seeks to increase the number of foreign facility inspections and establish permanent operations in China.
In response to this growing threat to the American people, Aim & Act, Incorporated, a small Montana firm, is seeking to work with Chinese manufacturers to provide safer products to the United States. Aim & Act provides scientific marketing and consulting services internationally to pharmaceutical, alternative medicine and medical device companies. With significant competency in Quality Assurance, Good Manufacturing Practices, Good Laboratory Practices, Primary Research as well as Process Design and Validation, Aim & Act is one of the only companies willing or able to take on this problem.
By concentrating much of its effort on Chinese companies and production facilities, Aim & Act hopes to assist foreign companies in applying the same standards of excellence in manufacturing found in the United States. Andrew Buirge, President of Consulting for Aim & Act said “Dietary supplement regulations have historically been especially lax, but as consumable products, it’s important that they adhere to the same standards that pharmaceuticals are subject to.” Aim & Act hopes to stop other unnecessary contaminations before they happen. In less than one week, most manufacturing processes can complete a quality assurance audit. This detailed examination of each step in a manufacturing process identifies any problem areas and reduces the possibility of contaminations to virtually none.
“Inconsistencies and contaminations in manufacturing are easily avoided with a relatively minor investment of time and money” said Buirge “but these kinds of contaminations are continuing to happen far too frequently and innocent people are dying because of it.” Enforcing high standards of excellence is not only important for consumer safety but for the continued viability of nutraceutical and other consumable goods companies.
Through a unique business model, Aim & Act bridges the traditional gap between marketing and science for foreign and domestic companies, thereby facilitating greater product uptake and return on investment for client companies.
Visit Aim & Act online at: www.Aim-Act.com, or call 406-585-5593